🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The drug olaparib may stop cancer cells from fixing damage to ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-07-11
Trial ID
NCT03531840
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
dMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-31
Trial ID
NCT07259473
Treatments Being Tested
This clinical trial will be conducted as a single-center, open-label, Phase...
Status
Terminated
Location
University of Iowa Hospitals and Clinics
Start Date
2020-10-05
Trial ID
NCT04108481
Treatments Being Tested
This is a Phase II, single arm study looking at the rate of major clinical ...
Status
Recruiting
Location
University of Iowa Hospitals & Clinics
Start Date
2023-03-24
Trial ID
NCT05239546
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
This study will evaluate the safety, and tolerability of Cadonilimab as neo...
Status
Unknown
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2023-06-20
Trial ID
NCT05913570
Treatments Being Tested
This study aims to explore the optimal number of cycles of PD-1 monotherapy...
Status
Recruiting
Location
Xijing hospital
Start Date
2025-01-01
Trial ID
NCT06613165
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
The purpose of this study is to find out whether the combination of botensi...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-20
Trial ID
NCT06843434
Treatments Being Tested